The BIO KOREA 2009 Conference consisting of 20 tracks and 60 sessions promise to be another outstanding academic and professional development experience. In particular, plenary session, the highlight of the conference, will provide you with great ideas to discover challenges and upgrade yourself for your future.
The plenary speeches at the BIO KOREA 2009 Conference by Dr. Richard Timothy Hunt who won the 2001 Nobel prize in physiology or medicine for the discovery of key regulators of cell division and cell cycle and Mr. Steven Burrill, CEO of Burrill & Co., who was selected as one of the 50 leaders in global science and technology by Scientific American, one of the most prestigious science magazines, in 2002 are already in the spotlight.
We hope you to read the trends in bio-health industry, forecast its future and get a competitive edge with the world-leading experts at the BIO KOREA 2009 Conference where the future of high-tech bio-health industry in the 21st century will begin.
※ Anyone who registers for the BIO KOREA 2009 is eligible for admission to plenary session for free
without additional registration for the conference. Please be sure to wear your name badge for
admission.
Plenary Speech Ⅰ
 |
Dr. Tim Hunt (Sir Richard Timothy Hunt) Principal Scientist Cancer Research UK Clare Hall Laboratories |
|---|
Dr. Tim Hunt is an English biochemist and a Principal Scientist at Cancer Research UK Clare Hall Laboratories, in South Mimms, Hertfordshire. In 2001, he was awarded the Nobel Prize in Physiology or Medicine with Leland Hartwell and Sir Paul Nurse for their discoveries regarding cell cycle regulation by cyclin and cyclin-dependent kinases. He also won the Abraham White Scientific Achievement Award of the George Washington University in 1993. In 2006, he was knighted by the Queen. He currently serves as chairman of the council of EMBO, ‘The European Molecular Biology Organization. |
Plenary Speech Ⅱ
 |
G. Steven Burrill CEO Burrill & Company |
|---|
G. Steven Burrill is CEO of Burrill & Company, the life sciences firm focused on venture capital, private equity, merchant banking and media. In 2002, Mr. Burrill was recognized as the Scientific American 50 by the prestigious Scientific American magazine. Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and coordinating the firm’s services to clients in the biotechnology/life sciences/high technology/manufacturing industries worldwide. He was also involved in establishing Amgen and Genetech, number one and two ranked biotechnology companies in the US. He is a biotech investment visionary currently managing over $1,000 million of biotech investment. |
Plenary Speech Ⅲ
 |
Jeong-Sun SEO Professor, College of Medicine, Seoul National University |
|---|
|
Dr. Jeong-Sun Seo is a professor of Biochemistry at Seoul National University, College of Medicine, and the director of Ilchun Genomic Medicine Institute (GMI-SNU). GMI-SNU is exclusively dedicated to Asian genome analysis to bring forth the era of personal medicine through accomplishing whole genome analysis of Asian population. Dr. Seo is a pioneer in Asian genome study; his group recently published his work on Korean whole genome analysis, being 4th group in the world to publish whole genome study in Nature utilizing NGS technology. His group also completed the whole genome analysis of a Korean female which will be the first Asian female whole genome sequence published to date. Dr. Seo was the president of the Korea Genome Organization, and is now the president of the unified Korean Society for Biochemistry and Molecular Biology. He is also the founder of Macrogen, a leading Korean bio-venture company listed in KOSDAQ as the first bio-venture company in Korea. He is also the first president of the Korea BIO Association. |